1-8 of 8
Nurulhuda Mustafa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Extracellular Vesicles Secreted from Daratumumab Resistant Cells Promote Resistance and Proliferation of Daratumumab Sensitive Cells, Possibly through the Transfer of miRNA Cargo

Irfan Azaman, Wee-Joo Chng, Nurulhuda Mustafa, Sanjay De Mel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1443.
https://doi.org/10.1182/blood-2023-185134
Published: 2023
Journal Articles

Novel Protac-Based EZH2 Degraders Effectively Target EZH2-Driven Lymphoid Malignancies By Abolishing Both Methylation-Dependent and -Independent Functions

Nurulhuda Mustafa, Zubaida Talal Alnaseri, Darrel Egk Jian Tan, Irfan Azaman, David Thanh Truong Quach, Wan Hsin Lim, Wee-Joo Chng
Journal: Blood
Blood (2023) 142 (Supplement 1): 4183.
https://doi.org/10.1182/blood-2023-190382
Published: 2023
Journal Articles

Daratumumab Resistant Natural Killer/T-Cell Lymphoma Exhibit an Addiction to the Exosome Biogenesis Pathway for Survival

Nurulhuda Mustafa, Muhamad Irfan Azaman, Wee-Joo Chng
Journal: Blood
Blood (2021) 138 (Supplement 1): 2256.
https://doi.org/10.1182/blood-2021-151812
Published: 2021
Journal Articles

MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma

Boheng Li, Junli Yan, The Phyu, Shuangyi Fan, Tae-Hoon Chung, Nurulhuda Mustafa, Baohong Lin, Lingzhi Wang, Pieter Johan Adam Eichhorn, Boon-Cher Goh, Siok-Bian Ng, Dennis Kappei, Wee-Joo Chng
Journal: Blood
Blood (2019) 134 (23): 2046–2058.
https://doi.org/10.1182/blood.2019000381
Published: 2019
Includes: Supplemental data
Journal Articles

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

Nurulhuda Mustafa, PhD, Adina Huey Fang Nee, BSc, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, BSc, Yan Ting Hee, BSc, Viknesvaran Selvarajan, PhD, Longen Zhou, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2018-99-115566
Published: 2018
Journal Articles

Daratumumab Efficiently Targets NK/T Cell Lymphoma with High CD38 Expression

Nurulhuda Mustafa, PhD, Huey Fang Adina Nee, BSc, Xue Ting Jeannie Lee, BSc, Wei Jin, PhD, Yiling Yu, PhD, Yingnan Chen, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, MRCP, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2814.
https://doi.org/10.1182/blood.V130.Suppl_1.2814.2814
Published: 2017
Journal Articles

MMSET Regulates IRF4, a Transcription Factor Critical for the Survival of T(4;14) Myeloma Myeloma Cells, and Its Silence Potentiates the Effect of Antimyeloma Agents

Zhigang Xie, PhD, Chonglei Bi, B.S, Jing Yuan Chooi, B.S, Zit Liang Chan, B.S, Nurulhuda Mustafa, PhD, Wee Joo Chng, MD PhD
Journal: Blood
Blood (2014) 124 (21): 171.
https://doi.org/10.1182/blood.V124.21.171.171
Published: 2014
Journal Articles

A Novel and Highly Selective Dual PI3K/mTOR Kinase Inhibitor VS-5584, Shows Promising Therapeutic Potential For The Treatment Of Multiple Myeloma

Nurulhuda Mustafa, PhD, Biomedical Science, Stefan Hart, PhD, Wee-Joo Chng
Journal: Blood
Blood (2013) 122 (21): 4433.
https://doi.org/10.1182/blood.V122.21.4433.4433
Published: 2013